Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects.

× No keyword cloud information.

26 in total

1. Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease.

Authors: Teddy Kosoglou; Walter K Kraft; Bharath Kumar; Paul Statkevich; Fengjuan Xuan; Lei Ma; Lisa K Jennings; James E Schiller; Ronald B Langdon; David L Cutler
Journal: Eur J Clin Pharmacol Date: 2012-02-08 Impact factor: 2.953

2. Mutation-prone points in thrombin receptor.

Authors: Viroj Wiwanitkit
Journal: J Thromb Thrombolysis Date: 2007-12-07 Impact factor: 2.300

Review 3. PAR-1 inhibitor antiplatelet agents: performance below par?

Authors: Arun Natarajan; Refai Showkathali; Kare Tang
Journal: Indian Heart J Date: 2012-09-12

4. Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxar.

Authors: Mariappan V Chelliah; Keith Eagen; Zhuyan Guo; Samuel Chackalamannil; Yan Xia; Hsingan Tsai; William J Greenlee; Ho-Sam Ahn; Stan Kurowski; George Boykow; Yunsheng Hsieh; Madhu Chintala
Journal: ACS Med Chem Lett Date: 2014-03-11 Impact factor: 4.345

5. Discovery of Octahydroindenes as PAR1 Antagonists.

Authors: Sunkyung Lee; Jong-Hwan Song; Chul Min Park; Jin-Seok Kim; Ji-Hye Jeong; Woo-Young Cho; Dong-Chul Lim
Journal: ACS Med Chem Lett Date: 2013-09-10 Impact factor: 4.345

6. Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxar.

Authors: Mariappan V Chelliah; Samuel Chackalamannil; Yan Xia; William J Greenlee; Ho-Sam Ahn; Stan Kurowski; George Boykow; Yunsheng Hsieh; Madhu Chintala
Journal: ACS Med Chem Lett Date: 2013-12-18 Impact factor: 4.345

Review 7. Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555.

Authors: Sergio Leonardi; Pierluigi Tricoci; Richard C Becker
Journal: Drugs Date: 2010-10-01 Impact factor: 9.546

Review 8. Antiplatelet therapy: thrombin receptor antagonists.

Authors: Antonio Tello-Montoliu; Salvatore D Tomasello; Masafumi Ueno; Dominick J Angiolillo
Journal: Br J Clin Pharmacol Date: 2011-10 Impact factor: 4.335

Review 9. Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?

Authors: R C Chambers
Journal: Br J Pharmacol Date: 2008-01-28 Impact factor: 8.739

Review 10. Platelet thrombin receptor antagonism and atherothrombosis.

Authors: Dominick J Angiolillo; Davide Capodanno; Shinya Goto
Journal: Eur Heart J Date: 2009-11-30 Impact factor: 29.983